Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10

European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009)

(2011) Niels Adriaenssens et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence of Ciprofloxacin-Nonsusceptible Streptococcus pyogenes Isolates from Healthy Children and Pediatric Patients in Portugal

(2010) R. Pires et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution

(2010) K. Arai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence and Clonal Characterization of Streptococcus pyogenes Clinical Isolates with Reduced Fluoroquinolone Susceptibility in Spain

(2009) M. Montes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations

(2009) Pierre Robert Smeesters et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin

(2009) Surbhi Malhotra-Kumar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes

(2008) S. Steve Yan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE